{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:50:08Z","timestamp":1783511408457,"version":"3.55.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Systems vaccinology has been applied to detect signatures of human vaccine induced immunity but its ability, together with high definition <jats:italic>in vivo<\/jats:italic> clinical imaging is not established to predict vaccine reactogenicity. Within two European Commission funded high impact programs, BIOVACSAFE and ADITEC, we applied high resolution positron emission tomography\/computed tomography (PET\/CT) scanning using tissue-specific and non-specific radioligands together with transcriptomic analysis of muscle biopsies in a clinical model systematically and prospectively comparing vaccine-induced immune\/inflammatory responses. 109 male participants received a single immunization with licensed preparations of either AS04-adjuvanted hepatitis B virus vaccine (AHBVV); MF59C-adjuvanted (ATIV) or unadjuvanted seasonal trivalent influenza vaccine (STIV); or alum-OMV-meningococcal B protein vaccine (4CMenB), followed by a PET\/CT scan (n\u00a0= 54) or an injection site muscle biopsy (n = 45). Characteristic kinetics was observed with a localized intramuscular focus associated with increased tissue glycolysis at the site of immunization detected by <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose (FDG) PET\/CT, peaking after 1\u20133 days and strongest and most prolonged after 4CMenB, which correlated with clinical experience. Draining lymph node activation peaked between days 3\u20135 and was most prominent after ATIV. Well defined uptake of the immune cell-binding radioligand <jats:sup>11<\/jats:sup>C-PBR28 was observed in muscle lesions and draining lymph nodes. Kinetics of muscle gene expression module upregulation reflected those seen previously in preclinical models with a very early (~6hrs) upregulation of monocyte-, TLR- and cytokine\/chemokine-associated modules after AHBVV, in contrast to a response on day 3 after ATIV, which was bracketed by whole blood responses on day 1 as antigen presenting, inflammatory and innate immune cells trafficked to the site of immunization, and on day 5 associated with activated CD4+ T cells. These observations confirm the use of PET\/CT, including potentially tissue-, cell-, or cytokine\/chemokine-specific radioligands, is a safe and ethical quantitative technique to compare candidate vaccine formulations and could be safely combined with biopsy to guide efficient collection of samples for integrated whole blood and tissue systems vaccinology in small-scale but intensive human clinical models of immunization and to accelerate clinical development and optimisation of vaccine candidates, adjuvants, and formulations.<\/jats:p>","DOI":"10.3389\/fimmu.2020.613496","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T03:53:07Z","timestamp":1612669987000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Systematic Evaluation of Kinetics and Distribution of Muscle and Lymph Node Activation Measured by 18F-FDG- and 11C-PBR28-PET\/CT Imaging, and Whole Blood and Muscle Transcriptomics After Immunization of Healthy Humans With Adjuvanted and Unadjuvanted Vaccines"],"prefix":"10.3389","volume":"11","author":[{"given":"Zarni","family":"Win","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"January","family":"Weiner 3rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Listanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neva","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldona","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Maertzdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Mollenkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kat","family":"Pizzoferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline L.","family":"Bodinham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H. E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Denoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J. M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.02.031","article-title":"Challenges in early clinical development of adjuvanted vaccines","author":"Della Cioppa","year":"2015","journal-title":"Vaccine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002398","article-title":"Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic","volume":"38","author":"Edwards","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.064","article-title":"Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohort and case-control studies","volume":"35","author":"Kassim","year":"2017","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a029256","article-title":"Will Systems Biology Deliver Its Promise and Contribute to the Development of New or Improved Vaccines? Systems Biology Views of Vaccine Innate and Adaptive Immunity","volume":"10","author":"Rappuoli","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/srep39097","article-title":"Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants","volume":"6","author":"Olafsdottir","year":"2016","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2012.10.005","article-title":"Potential use of inflammation and early immunological event biomarkers in assessing vaccine safety","volume":"41","author":"Mastelic","year":"2013","journal-title":"Biologicals"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00878","article-title":"Editorial: Advanced Immunization Technologies for Next Generation Vaccines","volume":"11","author":"Medaglini","year":"2020","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"128cm4","DOI":"10.1126\/scitranslmed.3003826","article-title":"ADITEC: joining forces for next-generation vaccines","volume":"4","author":"Rappuoli","year":"2012","journal-title":"Sci Transl Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.72","article-title":"Impact of the Innovative Medicines Initiative on vaccine development","volume":"17","author":"Denoel","year":"2018","journal-title":"Nat Rev Drug Discovery"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/909406","article-title":"Application of \u201cSystems Vaccinology\u201d to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines","volume":"2015","author":"Lewis","year":"2015","journal-title":"J Immunol Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.22038\/aojnmb.2017.8702","article-title":"Generalized Lymph Node Activation after Influenza Vaccination on (18)F FDG-PET\/CT Imaging, an Important Pitfall in PET Interpretation","volume":"5","author":"Ayati","year":"2017","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/1450-1147.176886","article-title":"A Unique Case of Increased 18F-FDG Metabolic Activity in the Soft Tissues of the Bilateral Upper Thighs Due to Immunizations in a Pediatric Patient","volume":"16","author":"Galloway","year":"2017","journal-title":"World J Nucl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-015-0385-6","article-title":"Systemic Immune Response to Vaccination on FDG-PET\/CT","volume":"50","author":"Mingos","year":"2016","journal-title":"Nucl Med Mol Imaging"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2011.26.2.210","article-title":"False-positive hypermetabolic lesions on post-treatment PET-CT after influenza vaccination","volume":"26","author":"Kim","year":"2011","journal-title":"Korean J Intern Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3182177322","article-title":"Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine","volume":"36","author":"Burger","year":"2011","journal-title":"Clin Nucl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-010-1719-5","article-title":"FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1)","volume":"20","author":"Panagiotidis","year":"2010","journal-title":"Eur Radiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-011-0568-x","article-title":"Axillary lymph node accumulation on FDG-PET\/CT after influenza vaccination","volume":"26","author":"Shirone","year":"2012","journal-title":"Ann Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1729-9","article-title":"Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination","volume":"38","author":"Thomassen","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001603","article-title":"Lymph Node Activation by PET\/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses","volume":"42","author":"Coates","year":"2017","journal-title":"Clin Nucl Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.46149","article-title":"Identification of potential biomarkers of vaccine inflammation in mice","volume":"8","author":"McKay","year":"2019","journal-title":"Elife"},{"key":"B23","doi-asserted-by":"publisher","first-page":"20362","DOI":"10.1038\/s41598-019-56994-8","article-title":"Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium","volume":"9","author":"Weiner","year":"2019","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41541-020-0177-6","article-title":"Pregnancy has a minimal impact on the acute transcriptional signature to vaccination","volume":"5","author":"Tregoning","year":"2020","journal-title":"NPJ Vaccin"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21945","article-title":"Suction-modified Bergstrom muscle biopsy technique: experience with 13,500 procedures","volume":"43","author":"Tarnopolsky","year":"2011","journal-title":"Muscle Nerve"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.119.236109","article-title":"Assessing PET Parameters in Oncologic (18)F-FDG Studies","volume":"48","author":"Sarikaya","year":"2020","journal-title":"J Nucl Med Technol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz447","article-title":"Gene set enrichment for reproducible science: comparison of CERNO and eight other algorithms","volume":"35","author":"Zyla","year":"2019","journal-title":"Bioinformatics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.05.012","article-title":"A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus","volume":"29","author":"Chaussabel","year":"2008","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00006231-200404000-00040","article-title":"SUVpeak: a new parameter for quantification of uptake in FDG PET","volume":"25","author":"Julyan","year":"2004","journal-title":"Nucl Med Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.115.161745","article-title":"Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study","volume":"43","author":"Akamatsu","year":"2015","journal-title":"J Nucl Med Technol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S2352-4642(18)30103-2","article-title":"Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study","volume":"2","author":"Bryan","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"B33","unstructured":"Meningococcal B Vaccination Information for healthcare professionals2019"},{"key":"B34","unstructured":"Bexsero Meningococcal Group B vaccine for injection in pre-filled syringe2019"},{"key":"B35","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00562","article-title":"A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity","volume":"7","author":"Dowling","year":"2016","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0235","article-title":"Assessment of Total Lesion Glycolysis by (18)F FDG PET\/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma","volume":"23","author":"McDonald","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.090","article-title":"Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes","volume":"29","author":"Calabro","year":"2011","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0185843","DOI":"10.1371\/journal.pone.0185843","article-title":"Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells","volume":"12","author":"Cioncada","year":"2017","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402071","article-title":"MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life","volume":"194","author":"Mastelic Gavillet","year":"2015","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0157066","DOI":"10.1371\/journal.pone.0157066","article-title":"Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans","volume":"11","author":"Spensieri","year":"2016","journal-title":"PloS One"},{"key":"B42","unstructured":"Immunisation against infectious disease2014"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 - an innately attractive adjuvant formulation","volume":"30","author":"O\u2019Hagan","year":"2012","journal-title":"Vaccine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: A review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23860","article-title":"Local anesthetic effects on gene transcription in human skeletal muscle biopsies","volume":"48","author":"Trappe","year":"2013","journal-title":"Muscle Nerve"},{"key":"B48","unstructured":"Ionising radiation: dose comparisons2011"},{"key":"B49","volume-title":"Documents of the National Radiation Protection Board","author":"McKinlay AF","year":"1993"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.4065\/mcp.2010.0260","article-title":"Radiation risk from medical imaging","volume":"85","author":"Lin","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25251","article-title":"Integrated magnetic resonance imaging and [(11) C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis","volume":"83","author":"Alshikho","year":"2018","journal-title":"Ann Neurol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.03.011","article-title":"Translocator protein localises to CD11b(+) macrophages in atherosclerosis","volume":"284","author":"Kopecky","year":"2019","journal-title":"Atherosclerosis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.202200","article-title":"Translocator Protein as an Imaging Marker of Macrophage and Stromal Activation in Rheumatoid Arthritis Pannus","volume":"59","author":"Narayan","year":"2018","journal-title":"J Nucl Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.11.2321","article-title":"The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity","volume":"123","author":"Banati","year":"2000","journal-title":"Brain"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05625-2","article-title":"In-vivo measurement of activated microglia in dementia","volume":"358","author":"Cagnin","year":"2001","journal-title":"Lancet"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2008.08.001","article-title":"Microglia, amyloid, and cognition in Alzheimer\u2019s disease: An [11C](R)PK11195-PET and [11C]PIB-PET study","volume":"32","author":"Edison","year":"2008","journal-title":"Neurobiol Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90576-o","article-title":"Monitoring by PET of macrophage accumulation in brain after ischaemic stroke","volume":"339","author":"Ramsay","year":"1992","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","article-title":"An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28","volume":"32","author":"Owen","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2711-0","article-title":"Human germinal centres engage memory and naive B cells after influenza vaccination","volume":"586","author":"Turner","year":"2020","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.613496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T03:53:16Z","timestamp":1612669996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.613496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2020.613496"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.613496","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"article-number":"613496"}}